202 related articles for article (PubMed ID: 17407628)
1. Asthma control in patients with asthma and allergic rhinitis receiving add-on montelukast therapy for 12 months: a retrospective observational study.
Borderias L; Mincewicz G; Paggiaro PL; Guilera M; Sazonov Kocevar V; Taylor SD; Badia X
Curr Med Res Opin; 2007 Apr; 23(4):721-30. PubMed ID: 17407628
[TBL] [Abstract][Full Text] [Related]
2. Healthcare utilisation and costs associated with adding montelukast to current therapy in patients with mild to moderate asthma and co-morbid allergic rhinitis: PRAACTICAL study.
Dal Negro R; Piskorz P; Vives R; Guilera M; Sazonov Kocevar V; Badia X
Pharmacoeconomics; 2007; 25(8):665-76. PubMed ID: 17640108
[TBL] [Abstract][Full Text] [Related]
3. Rates of asthma attacks in patients with previously inadequately controlled mild asthma treated in clinical practice with combination drug therapy: an exploratory post-hoc analysis.
Dal Negro RW; Borderias L; Zhang Q; Fan T; Sazonov V; Guilera M; Taylor SD
BMC Pulm Med; 2009 Mar; 9():10. PubMed ID: 19331689
[TBL] [Abstract][Full Text] [Related]
4. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
[TBL] [Abstract][Full Text] [Related]
5. Montelukast in general pediatric practices.
Ngamphaiboon J
J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S348-51. PubMed ID: 16623053
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of add-on montelukast in patients with non-controlled asthma: a Belgian open-label study.
Korn D; Van den Brande P; Potvin E; Dramaix M; Herbots E; Peché R
Curr Med Res Opin; 2009 Feb; 25(2):489-97. PubMed ID: 19192994
[TBL] [Abstract][Full Text] [Related]
7. Montelukast as add-on therapy with inhaled corticosteroids alone or inhaled corticosteroids and long-acting beta-2-agonists in the management of patients diagnosed with asthma and concurrent allergic rhinitis (the RADAR trial).
Keith PK; Koch C; Djandji M; Bouchard J; Psaradellis E; Sampalis JS; Schellenberg RR; McIvor RA
Can Respir J; 2009; 16 Suppl A(Suppl A):17A-31A. PubMed ID: 19557208
[TBL] [Abstract][Full Text] [Related]
8. The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis.
Philip G; Nayak AS; Berger WE; Leynadier F; Vrijens F; Dass SB; Reiss TF
Curr Med Res Opin; 2004 Oct; 20(10):1549-58. PubMed ID: 15462688
[TBL] [Abstract][Full Text] [Related]
9. Asthma and allergy medication use and costs among pediatric primary care patients on asthma controller therapy.
Sazonov-Kocevar V; Laforest L; Travier N; Yin DD; Van Ganse E
Pediatr Allergy Immunol; 2006 Dec; 17(8):620-8. PubMed ID: 17121591
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: a subgroup analysis of the investigation of montelukast as a partner agent for complementary therapy [corrected].
Bousquet J; Gaugris S; Kocevar VS; Zhang Q; Yin DD; Polos PG; Bjermer L
Clin Exp Allergy; 2005 Jun; 35(6):723-7. PubMed ID: 15969661
[TBL] [Abstract][Full Text] [Related]
11. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
Dupont L; Potvin E; Korn D; Lachman A; Dramaix M; Gusman J; Peché R;
Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886
[TBL] [Abstract][Full Text] [Related]
12. Patient characteristics and prescription fill patterns for allergic rhinitis medications, with a focus on montelukast, in a commercially insured population.
Bollinger ME; Diette GB; Chang CL; Stephenson JJ; Sajjan SG; Fan T; Allen-Ramey FC
Clin Ther; 2010 Jun; 32(6):1093-102. PubMed ID: 20637964
[TBL] [Abstract][Full Text] [Related]
13. Treatment and outcomes in patients with asthma and allergic rhinitis in the United kingdom.
Zhang Q; Thomas M; Wisniewski T; Sazonov Kocevar V; Price D
Int Arch Allergy Immunol; 2007; 142(4):318-28. PubMed ID: 17135763
[TBL] [Abstract][Full Text] [Related]
14. Montelukast in pediatric asthma management.
Walia M; Lodha R; Kabra SK
Indian J Pediatr; 2006 Apr; 73(4):275-82. PubMed ID: 16816486
[TBL] [Abstract][Full Text] [Related]
15. A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma.
Wilson AM; Dempsey OJ; Sims EJ; Lipworth BJ
Clin Exp Allergy; 2001 Apr; 31(4):616-24. PubMed ID: 11359431
[TBL] [Abstract][Full Text] [Related]
16. Marginal utility of montelukast for persistent asthma.
Mathison DA; Koziol JA
Chest; 2002 Feb; 121(2):334-7. PubMed ID: 11834640
[TBL] [Abstract][Full Text] [Related]
17. Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study.
Ilowite J; Webb R; Friedman B; Kerwin E; Bird SR; Hustad CM; Edelman JM
Ann Allergy Asthma Immunol; 2004 Jun; 92(6):641-8. PubMed ID: 15237766
[TBL] [Abstract][Full Text] [Related]
18. Montelukast in the treatment of allergic rhinitis: an evidence-based review.
Nayak A; Langdon RB
Drugs; 2007; 67(6):887-901. PubMed ID: 17428106
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of desloratadine versus montelukast on asthma symptoms and use of beta 2-agonists in patients with seasonal allergic rhinitis and asthma.
Baena-Cagnani CE; Berger WE; DuBuske LM; Gurné SE; Stryszak P; Lorber R; Danzig M
Int Arch Allergy Immunol; 2003 Apr; 130(4):307-13. PubMed ID: 12740532
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.
Virchow JC; Bachert C
Respir Med; 2006 Nov; 100(11):1952-9. PubMed ID: 16626955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
